In this audio interview I discuss with Dr. Prakash Masand key concepts about treatment-resistant depression.

These include:

• Definitions of treatment-resistant depression.
• The concept of pseudoresistance in treatment-resistant depression: some considerations to keep in mind before labeling a patient as “treatment-resistant”.
• The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study:
  • Its strenghts and weaknesses
  • Its implications for clinical practice
• When to switch or augment antidepressants.
• Evidence base for augmentation strategies: second generation antipsychotics, lithium, T3, lisdexamfetamine, modafinil, methylphenidate, folate and CBT.
• How long should augmentation therapy be continued in MDD after remission.
• When to use MAOIs.

Click here for more education on psychopharmacology

The post The Basics of Treatment-Resistant Depression appeared first on Psychopharmacology Institute.

The post Differences between typical and atypical antipsychotics appeared first on Psychopharmacology Institute.